Clinical impact of COVID-19 respiratory infection 15 months after intensive care unit discharge

María-Lidón Mateu-Campos1, Susana Altaba-Tena2, Beatriz Boscá-Martínez2

  • 1Intensive Care Medicine Department, General University Hospital of Castellón, Avenida Benicassim 128, 12004, Castellón de la Plana, Spain; Predepartmental Unit of Medicine, Jaume I University, Castellón Avenida Vicente Sos Baynat s/n, 12006, Castellón de la Plana, Spain.

Medicina Intensiva
|June 21, 2025
PubMed

Insights

Persistent COVID-19 symptoms impact physical, cognitive, and psychological health 15 months post-ICU. Caregivers also experience significant burden from long COVID patients.

Area of Science:

  • Intensive Care Medicine
  • Infectious Diseases
  • Rehabilitation Medicine

Background:

  • Long COVID, or persistent symptoms following SARS-CoV-2 infection, presents a significant public health challenge.
  • Understanding the long-term sequelae of severe COVID-19, particularly in patients requiring intensive care, is crucial for effective management and rehabilitation.

Purpose of the Study:

  • To assess the prevalence of persistent COVID-19 symptoms 15 months after ICU discharge.
  • To evaluate the impact of these symptoms on physical, psychological, and neurocognitive functions.
  • To determine the burden experienced by primary caregivers of long COVID patients.

Main Methods:

  • A descriptive, ambispective observational study was conducted.
  • 85 patients discharged from an Intensive Care Unit (ICU) after SARS-CoV-2 infection were evaluated.
  • Data collected included demographics, hospitalization details, persistent symptoms questionnaires, functional tests (6-Minute Walk Test), anxiety (Beck Anxiety Inventory), PTSD, and caregiver burden (Zarit Caregiver Burden Scale).

Main Results:

  • High prevalence of musculoskeletal disorders (arthralgia 44.7%, myalgia 38.2%), cognitive impairments (52.9%), sleep disturbances (34.1%), asthenia (44.5%), and anxiety (34.5%) were reported.
  • Psychological distress was evident, with 29.4% reporting "fear of the worst" and 35% experiencing recurrent ICU memories.
  • Caregivers reported significant burden, with 22.2% finding caregiving a substantial challenge.

Conclusions:

  • Persistent COVID-19 significantly affects physical, cognitive, and psychological domains in former ICU patients.
  • The long-term effects extend to primary caregivers, highlighting a dual burden on patients and their support systems.
  • This underscores the need for comprehensive, long-term follow-up care for severe COVID-19 survivors.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
349
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
432
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
311
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
315
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
200
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
326